I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Table1_Stevens–Johnson syndrome induced by toripalimab in a..:
Yang Chen
;
Hanhan Hong
;
Shujun Bao
.
doi:10.3389/fphar.2023.1131703.s001. , 2023
Link:
https://doi.org/10.3389/fphar.2023.1131703.s001
RT Journal T1
Table1_Stevens–Johnson syndrome induced by toripalimab in a previously EGFR-TKI-treated advanced lung adenocarcinoma patient harboring EGFR mutations 19 del/T790M/C797S in trans and cis: a case report.docx
UL https://suche.suub.uni-bremen.de/peid=base-ftdeakinunifig:oai:figshare.com:article_24557464&Exemplar=1&LAN=DE A1 Yang Chen A1 Hanhan Hong A1 Shujun Bao A1 Hao Tang YR 2023 K1 Pharmacology K1 Basic Pharmacology K1 Clinical Pharmacology and Therapeutics K1 Clinical Pharmacy and Pharmacy Practice K1 Pharmaceutical Sciences K1 Pharmacogenomics K1 Toxicology (incl. Clinical Toxicology) K1 Pharmacology and Pharmaceutical Sciences not elsewhere classified K1 Stevens–Johnson syndrome K1 adverse reaction K1 toripalimab K1 non-small-cell lung cancer K1 EGFR tyrosine kinase inhibitor JF doi:10.3389/fphar.2023.1131703.s001 LK http://dx.doi.org/https://doi.org/10.3389/fphar.2023.1131703.s001 DO https://doi.org/10.3389/fphar.2023.1131703.s001 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)